APA (7th ed.) Citation

Lessard, L., Larbi, S. B., Weiss-Gayet, M., Courchet, J., Furling, D., Gallay, L., & Mounier, R. (2025). 397PMetabolic and myogenic defects as a therapeutic target in type 1 myotonic dystrophy (DM1). Neuromuscular Disorders, 53, N.PAG. https://doi.org/10.1016/j.nmd.2025.105963

Chicago Style (17th ed.) Citation

Lessard, L., S. Ben Larbi, M. Weiss-Gayet, J. Courchet, D. Furling, L. Gallay, and R. Mounier. "397PMetabolic and Myogenic Defects as a Therapeutic Target in Type 1 Myotonic Dystrophy (DM1)." Neuromuscular Disorders 53 (2025): N.PAG. https://doi.org/10.1016/j.nmd.2025.105963.

MLA (9th ed.) Citation

Lessard, L., et al. "397PMetabolic and Myogenic Defects as a Therapeutic Target in Type 1 Myotonic Dystrophy (DM1)." Neuromuscular Disorders, vol. 53, 2025, p. N.PAG, https://doi.org/10.1016/j.nmd.2025.105963.